Panadol night
GlaxoSmithKline painkiller intended for use at night
Panadol night is a GlaxoSmithKline painkiller intended for use at night. It consists of 500 milligrams of paracetamol, 25 milligrams of diphenhydramine hydrochloride (a sedating antihistamine) and other "non-hazardous ingredients". It is sold in Australia, Cyprus, United Kingdom, Ireland, New Zealand and the Middle East. It became available as an over the counter medication in the UK in 1996.
Active ingredients
Panadol night tablets contain two active ingredients, paracetamol and diphenhydramine.
Although paracetamol has been widely used for more than a hundred years, scientists still don't fully understand its bio-mechanisms. The main belief is that it reduces the production of prostaglandins in the brain and spinal cord.
Diphenhydramine is a sedating H1 antagonist. Diphenhydramine works by blocking the effects of histamine and causes drowsiness. The combination of the active ingredients in Panadol night can be used to relieve mild to moderate pain such as headaches, backache or period pain that is causing difficulty getting to sleep.
Begin with the source’s own compact description: “Panadol night” is glaxoSmithKline painkiller intended for use at night. The dossier treats that line as a proposition to test through Panadol, night and GlaxoSmithKline, not as a finished interpretation.
Why this record matters
The phrase “glaxoSmithKline painkiller intended for use at night” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Sep 15, 2025. The linked authority identifier is Q7129769. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1996.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Panadol night”, its source revision and the description used here.
- Expand the search: follow Panadol night primary sources, Panadol night archive and Panadol research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Panadol night”?
- What terminology or title could unlock a more precise catalogue search?
- Which cited source is closest to the event, object or claim?
Search terms from this dossier
This entry incorporates text from “Panadol night” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.